April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
The Impact Of Stop-smoking And Antioxidant Supplements On Patients With Chronic Central Serous Chorioretinopathy
Nana Tachi; Masayuki Ashikari; Tsutomu Yasukawa; Yoshio Hirano; Yuichiro Ogura
Author Affiliations & Notes
  • Nana Tachi
    Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
  • Masayuki Ashikari
    Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
  • Tsutomu Yasukawa
    Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
  • Yoshio Hirano
    Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
  • Yuichiro Ogura
    Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
  • Footnotes
    Commercial Relationships  Nana Tachi, None; Masayuki Ashikari, None; Tsutomu Yasukawa, None; Yoshio Hirano, None; Yuichiro Ogura, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4511. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      The Impact Of Stop-smoking And Antioxidant Supplements On Patients With Chronic Central Serous Chorioretinopathy
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Nana Tachi, Masayuki Ashikari, Tsutomu Yasukawa, Yoshio Hirano, Yuichiro Ogura; The Impact Of Stop-smoking And Antioxidant Supplements On Patients With Chronic Central Serous Chorioretinopathy. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4511.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : Chronic central serous chorioretinopathy (CSC) has persistent serous retinal detachment with indistinct or diffuse leakage on fluorescein angiography, resulting in gradual vision loss. Chronic CSC has pathological features partly similar to polypoidal choroidopathy. The purpose of the current study is to evaluate the impact of stopping smoking and antioxidant supplements on chronic CSC.

Methods: : Seventeen eyes of 15 patients with diagnosis of chronic CSC were enrolled, involving 12 eyes of 11 men and 5 eyes of 4 women. Averaged age was 55.5 ± 9.6 years. Mean follow-up period was 12.5 months. After diagnosed as chronic CSC, patients were guided so as to stop smoking for current smokers and take vitamin and mineral supplements (Ocuvite® Lutein: Bosch & Lomb; or Sante Lutax® 15: Santen Pharmaceutical Co.) for all patients. Serous retinal detachment (sRD) measured by optical coherence tomography (OCT) and visual acuity was assessed.

Results: : Seven patients (46.7%) were current smokers. While all of these patients could stop smoking, only 1 patient could not take supplements. Four patients (26.7%) were experienced smokers, and the other 4 patients (26.7%) nonsmokers. These patients all could take supplements. Of 10 eyes with OCT data at month 1, sRD was completely resolved in 5 eyes (50.0%), reduced in 3 eyes (30.0%), and same as preoperative volume in 2 eyes (20.0%). During the observation period, sRD was totally resolved in 11 of 17 eyes (64.7%) within averaged duration of 4.0 ± 3.1 months. Three eyes (17.6%) reduced sRD partially and the other 3 eyes (17.6%) had no change in sRD. Of 11 eyes with complete resolution of sRD, 3 eyes had recurrence of sRD because of re-start of smoking and/or stop of the take of supplements.

Conclusions: : Chronic CSC has been recently reported to be treatable by photodynamic therapy. However, it may be worthwhile for these patients to be observed for a few months with no-smoking and antioxidant supplements.

Keywords: antioxidants • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • retinal detachment 
© 2011, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept